MedPath

Diphenhydramine

Generic Name
Diphenhydramine
Brand Names
Acetadryl, Advil PM, Aleve PM, Allegra Cooling Relief Anti-itch, Banophen, Benadryl, Benadryl Itch Stopping, Benadryl-D Allergy and Sinus, Calagel, Damylin With Codeine, Dimetapp Nighttime Cold & Congestion, Diphen, Diphenhist, Diphenist, Excedrin PM Triple Action, Goody's PM, Legatrin PM, Motrin PM, Nytol, Nytol Quickgels, Percogesic Reformulated Jan 2011, Siladryl, Simply Sleep, Sleepinal, Sominex, Triaminic Night Time Cold & Cough, Tylenol PM, Unisom, Unisom Sleep, Vanamine, Wal-dryl, Wal-som (doxylamine), Zzzquil
Drug Type
Small Molecule
Chemical Formula
C17H21NO
CAS Number
58-73-1
Unique Ingredient Identifier
8GTS82S83M

Overview

Diphenhydramine - perhaps known most commonly as its brand name formulation Benadryl - is a first-generation H1 receptor antihistamine that is used extensively for the treatment of seasonal allergies, insect bites and stings, and rashes . However, it also has antiemetic, antitussive, hypnotic, and antiparkinson properties . As histamine receptors exist both peripherally and in the central nervous system, diphenhydramine has been shown to cause sedation due to its competitive antagonism of histamine H1 receptors within the central nervous system . While its use in allergy therapy can sometimes fall out of favor due to its sedative effect, diphenhydramine has been repurposed for use within many non-prescription over-the-counter sleep aids and cough-and-cold medications that have been marketed for "night time" use . Diphenhydramine is also used in combination with 8-chlorotheophylline as the anti-nausea drug Dimenhydrinate where it is utilized primarily for its antagonism of H1 histamine receptors within the vestibular system . Diphenhydramine has also been shown to be implicated in a number of neurotransmitter systems that affect behaviour including dopamine, norepinephrine, serotonin, acetylcholine, and opioid . As a result, diphenhydramine is being investigated for its anxiolytic and anti-depressant properties.

Background

Diphenhydramine - perhaps known most commonly as its brand name formulation Benadryl - is a first-generation H1 receptor antihistamine that is used extensively for the treatment of seasonal allergies, insect bites and stings, and rashes . However, it also has antiemetic, antitussive, hypnotic, and antiparkinson properties . As histamine receptors exist both peripherally and in the central nervous system, diphenhydramine has been shown to cause sedation due to its competitive antagonism of histamine H1 receptors within the central nervous system . While its use in allergy therapy can sometimes fall out of favor due to its sedative effect, diphenhydramine has been repurposed for use within many non-prescription over-the-counter sleep aids and cough-and-cold medications that have been marketed for "night time" use . Diphenhydramine is also used in combination with 8-chlorotheophylline as the anti-nausea drug Dimenhydrinate where it is utilized primarily for its antagonism of H1 histamine receptors within the vestibular system . Diphenhydramine has also been shown to be implicated in a number of neurotransmitter systems that affect behaviour including dopamine, norepinephrine, serotonin, acetylcholine, and opioid . As a result, diphenhydramine is being investigated for its anxiolytic and anti-depressant properties.

Indication

Diphenhydramine is a first-generation histamine H1 receptor antagonist (H1 antihistamine) that is widely available as a non-prescription, over-the-counter (OTC) medication. As an OTC medication, diphenhydramine is typically formulated as tablets and creams indicated for use in treating sneezing, runny nose, itchy/watery eyes, itching of nose or throat, insomnia, pruritis, urticaria, insect bites/stings, allergic rashes, and nausea . Additionally, when the use of oral diphenhydramine is impractical, there are also prescription-only formulations such as diphenhydramine injection products that are effective in adults and pediatric patients (other than premature infants and neonates) for: i) the amelioration of allergic reactions to blood or plasma, in anaphylaxis as an adjunct to epinephrine and other standard measures after acute allergic reaction symptoms have been controlled, and for other uncomplicated allergic conditions of the immediate type when oral therapy is impossible or contraindicated ; ii) the active treatment of motion sickness ; and iii) use in parkinsonism when oral therapy is impossible or contraindicated, as follows: parkinsonism in the elderly who are unable to tolerate more potent agents; mild cases of parkinsonism in other age groups, and in other cases of parkinsonism in combination with centrally acting anticholinergic agents .

Associated Conditions

  • Allergic Reaction
  • Allergic Rhinitis (AR)
  • Allergic cough
  • Allergy to Tree Pollen
  • Anaphylaxis
  • Angioedema
  • Common Cold
  • Conjunctival irritation
  • Cough
  • Cough Variant Asthma
  • Cough caused by Common Cold
  • Eye allergy
  • Fever
  • Insect Bites
  • Insect Stings
  • Insomnia
  • Irritative cough
  • Itching of the nose
  • Itching of the throat
  • Motion Sickness
  • Nasal Congestion
  • Oral Mucositis
  • Pain
  • Parkinsonian Syndromes
  • Productive cough
  • Pruritus
  • Rash
  • Rhinorrhoea
  • Sinus Congestion
  • Sinus headache
  • Skin Irritation
  • Sneezing
  • Sunburn
  • Symptoms of Acute Bronchitis Accompanied by Coughing
  • Upper respiratory tract hypersensitivity reaction, site unspecified
  • Urticaria
  • Cold or flu syndrome
  • Dermatographism
  • Dry cough
  • Watery itchy eyes

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/04/04
Phase 3
Not yet recruiting
2024/11/26
Phase 3
Not yet recruiting
2024/11/25
Phase 2
Not yet recruiting
2024/04/10
Phase 2
Recruiting
2024/04/03
Not Applicable
ENROLLING_BY_INVITATION
2024/03/15
Phase 4
Completed
2024/01/22
Phase 4
Recruiting
2024/01/16
Phase 1
Recruiting
2023/12/26
Not Applicable
Recruiting
2023/10/16
Phase 2
Recruiting

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Wal-Mart Stores Inc
49035-164
ORAL
25 mg in 1 1
5/28/2025
P & L Development, LLC
49580-0314
ORAL
50 mg in 30 mL
3/24/2025
HF Acquisition Co LLC, DBA HealthFirst
51662-1218
INTRAMUSCULAR, INTRAVENOUS
50 mg in 1 mL
2/19/2020
REMEDYREPACK INC.
70518-3685
INTRAVENOUS, INTRAMUSCULAR
50 mg in 1 mL
4/2/2024
Softgel Healthcare Pvt Ltd
35916-0472
ORAL
50 mg in 1 1
4/8/2025
Cardinal Health 110, LLC. DBA Leader
70000-0701
ORAL
12.5 mg in 5 mL
4/28/2025
Fresenius Kabi USA, LLC
63323-664
INTRAVENOUS, INTRAMUSCULAR
50 mg in 1 mL
10/3/2019
Whole Foods Market, INC.
42681-0051
ORAL
50 mg in 1 1
5/21/2025
Belleview Bioscience LLC
84447-128
ORAL
12.5 mg in 5 mL
6/17/2025
State of Florida DOH Central Pharmacy
53808-0238
ORAL
50 mg in 1 1
5/25/2010

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
BENOCTEN TABLET 50 mg
SIN00362P
TABLET
50 mg
4/23/1988
PAXIDORM TABLETS 25 mg
SIN10851P
TABLET, SUGAR COATED
25 mg
4/1/1999
PHENEXPECT SYRUP
SIN09014P
SYRUP
12.5 mg/5 ml
11/28/1996
DIPHEN 10 EXPECTORANT
SIN08799P
SYRUP
10 mg/5 ml
7/3/1996
SUNTUSS SYRUP
SIN03491P
SYRUP
10 mg/5 ml
6/24/1989
UNIDRYL CD EXPECTORANT
SIN02917P
SYRUP
14mg/5ml
5/22/1989
HOVA EXPECTORANT
SIN03251P
SYRUP
14 mg/5 ml
6/12/1989
DIPRODIN ELIXIR
SIN07830P
ELIXIR
12.5 mg/5 ml
9/1/1994
DIPRODIN ELIXIR
SIN07830P
ELIXIR
12.5 mg/5 ml
9/1/1994
SW-BENA PAEDIATRIC EXPECTORANT
SIN07609P
SYRUP
5 mg/5 ml
1/14/1994

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Diphenhydramine Hydrochloride Softgels
国药准字H20070315
化学药品
胶囊剂
3/2/2022
Diphenhydramine Hydrochloride Softgels
国药准字H20070314
化学药品
胶囊剂
3/2/2022
Diphenhydramine Hydrochloride Injection
国药准字H32021847
化学药品
注射剂
5/11/2020
Diphenhydramine Hydrochloride Injection
国药准字H61021679
化学药品
注射剂
4/20/2023
Diphenhydramine Hydrochloride Injection
国药准字H20053926
化学药品
注射剂
10/18/2023
Diphenhydramine Hydrochloride Injection
国药准字H42020696
化学药品
注射剂
1/3/2023
Diphenhydramine Hydrochloride Injection
国药准字H35020106
化学药品
注射剂
2/28/2020
Diphenhydramine Hydrochloride Injection
国药准字H42021175
化学药品
注射剂
7/13/2020
Diphenhydramine Hydrochloride Injection
国药准字H32021435
化学药品
注射剂
8/11/2020
Diphenhydramine Hydrochloride Injection
国药准字H41020225
化学药品
注射剂
2/24/2020

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
BACAMINE LOTION
N/A
N/A
N/A
3/25/1982
LONGAXON CREAM
N/A
unicorn laboratories o/b american unicorn laboratories limited
N/A
N/A
1/14/1997
CALAMINE-D LOTION
N/A
N/A
N/A
7/3/1979
AICADRYL LOTION
N/A
N/A
N/A
9/30/1981
RAPIDERM CREAM
N/A
unicorn laboratories o/b american unicorn laboratories limited
N/A
N/A
8/23/1999
CALAMINE WITH D.P.H CREAM
N/A
N/A
N/A
12/10/1983
TRIDAZINE-FORTE CREAM
N/A
N/A
N/A
9/28/2009
LAMEBA CREAM
N/A
N/A
N/A
3/21/2000
F-HANSONE CREAM
N/A
frankin pharmaceutical laboratories co ltd
N/A
N/A
12/14/1998
CALOX CREAM
N/A
N/A
N/A
2/22/1980
© Copyright 2025. All Rights Reserved by MedPath